Cognitive improvements in ocrelizumab-treated patients with relapsing-remitting multiple sclerosis: 96-week CASTING study data
38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis, Amsterdam, Netherlands, 26 - 28 October 2022, vol.28, pp.392-393, (Summary Text)
- Publication Type: Conference Paper / Summary Text
- Volume: 28
- City: Amsterdam
- Country: Netherlands
- Page Numbers: pp.392-393
- Istanbul University Affiliated: Yes